Metabolic Dysregulation and Antibody-Mediated Rejection After Kidney Transplantation: Interacting Mechanisms and Emerging Clinical Strategies - Takeaways - MDSpire

Metabolic Dysregulation and Antibody-Mediated Rejection After Kidney Transplantation: Interacting Mechanisms and Emerging Clinical Strategies

  • By

  • Yang, Qizhen

  • Chao, Sheng

  • Zhu, Kejing

  • Niu, Yulin

  • May 6, 2026

  • 0 min

Share

  • 1

    Kidney transplantation improves survival but is challenged by antibody-mediated rejection (ABMR) and metabolic complications.

  • 2

    ABMR is a leading cause of late graft failure, affecting kidney transplant outcomes significantly.

  • 3

    30% to 50% of kidney transplant recipients develop metabolic syndromes within the first year post-transplant.

  • 4

    Metabolic abnormalities can worsen ABMR, creating a vicious cycle that complicates patient management.

  • 5

    Integrated immunometabolic strategies are crucial for enhancing graft survival and patient health in kidney transplantation.

Original Source(s)

Metabolic Dysregulation and Antibody-Mediated Rejection After Kidney Transplantation: Interacting Mechanisms and Emerging Clinical Strategies

  • by Yang, Qizhen , Chao, Sheng , Zhu, Kejing , Niu, Yulin

  • May 6, 2026

Related Content

Investigating Metabolic and Inflammatory Patterns in Staging Cardiovascular-Kidney-Metabolic Syndrome: A Comparative Cross-Sectional Analysis

The interplay of maturity-onset diabetes of the young, obesity, uncontrolled hypertension, and cannabinoid hyperemesis in the progression to end-stage renal disease: a case report

Linking Stages of Cardiovascular-Kidney-Metabolic Syndrome to All-Cause Mortality Risk in U.S. Adults: Findings from a NHANES Cross-Sectional Analysis